Skip to main content

Education/ACR/EULAR

NEW QD Clinic Differential Dx Myalgias & Arthralgias https://t.co/ozawoe6RMO

Dr. John Cush RheumNow ( View Tweet)

Jan 21, 2021
Though provoking piece by Dr. Len Calabrese in Healio,He references Drs. Schett and Scher writing in Nature Reviews Rheumatology on KOLs. Both articles are about reflection on what we do, how we do it, what motivates us.

Dr. John Cush RheumNow ( View Tweet)

Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz common lab findings: hypergammaglobulinemia is common but elevated ESR/CRP are not. Most have elevated IgG4 serum levels @UTSWIMchief https://t.co/wR5FEqZTsX
Dr. John Cush RheumNow ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz commonly presents as major salivary and lacrimal gland enlargement, orbital disease, autoimmune pancreatitis, retroperitoneal (mass) fibrosis or tubulointerstitial nephritis. @UTSWIMchief

Dr. John Cush RheumNow ( View Tweet)

Jan 21, 2021
UTSW Rheum Grand Rounds - IgG4 Dz renal involvement; most common is tubulointerstitial nephritis @UTSWIMchief https://t.co/q8dZbgmvfK
Dr. John Cush RheumNow ( View Tweet)
Jan 21, 2021
UTSW Rheum Grand Rounds - Dr. Andres Quiceno on "IgG4 related Disease" Histologic criteria req >40% on IgG4/IgG cells @UTSWIMchief https://t.co/2kOioCdFiM
Dr. John Cush RheumNow ( View Tweet)
Jan 21, 2021
Inequities in Telemedicine During COVID-19 Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began but what if you don't have access to reliable technology?
Dr. John Cush RheumNow ( View Tweet)
Jan 21, 2021
Sign up to attend RheumNow Live--March 20 and 21. CME credits available https://t.co/vJlU0Z3Q3x https://t.co/Z0ectgFD2d
Dr. John Cush RheumNow ( View Tweet)
Jan 20, 2021

Inequities in Telemedicine During COVID-19

MedPage Today
Jan 19, 2021

Health equity in the telehealth age has assumed added importance since the COVID-19 pandemic began. The Federal Communications Commission estimates that about 21 million Americans don't have access to the Internet in their homes. Other sources estimate it is closer to 162 million. However,

Read Article
QD Clinic - Raynaud's or Not Lessons from the clinic an evaluation of blue fingers https://t.co/5EOvoM5jVf

Dr. John Cush RheumNow ( View Tweet)

Jan 19, 2021

Travel During COVID-19 Pandemic

Jan 18, 2021

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Read Article
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE
Dr. John Cush RheumNow ( View Tweet)
Jan 16, 2021

Copay Assistance Programs Help Patients but Confuse Them Too

MedPage Today
Jan 15, 2021

"If you're having trouble paying for your medications, Drug Company X may be able to help."



You may have heard sentences like this at the end of pharmaceutical ads on television, and some clinicians may wonder what exactly the companies do to help their patients. The help usually

Read Article

RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)

Jan 15, 2021

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...

Read Article

2020 Rheumatology Year in Review

Jan 14, 2021

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related. Below, are our top news items

Read Article

ProDERM Study: IVIG in Dermatomyositis

Jan 13, 2021

The ProDERM study design and outcomes are previewed in Medicine; and as promised the results were revealed at ACR Convergence in November 2020 showing that IVIg is safe, effective and superior to placebo i(PBO) in patients with dermatomyositis (DM).

Read Article
Survey of 428 Rheums in Brazil finds they are prone to promote physical activity; but less than 1/4 had training, 14% dont assess phys activity routinely, & half dont know minimum recommendations.

Dr. John Cush RheumNow ( View Tweet)

Jan 13, 2021
New year, new QD Clinic- Clinic Emergencies. https://t.co/xyaVP8ZkmB https://t.co/QXTvp2mttV
Dr. John Cush RheumNow ( View Tweet)
Jan 13, 2021
Download your RheumaKnowledgy Card https://t.co/L7O0UFjEBV https://t.co/iFtVKERnjC
Dr. John Cush RheumNow ( View Tweet)
Jan 12, 2021
RheumNow Podcast is up! Benlysta safety, HCQ lowers thromboses, HCQ adherence, Telemedicine, Actemra in COVID,, 2021 looking forward and zoomatology!

Dr. John Cush RheumNow ( View Tweet)

Jan 10, 2021
Our latest podcast is up—Lights, Camera, Zoom. We review the news, journal articles and blogs featured on RheumNow this week. Download wherever podcasts are available. https://t.co/8O5AWNa88d

Dr. John Cush RheumNow ( View Tweet)

Jan 10, 2021
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at ACR Convergence 2020?
Dr. John Cush RheumNow ( View Tweet)
Jan 09, 2021

Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo

MedPage Today
Jan 08, 2021

The fate of the Trump administration's "most favored nation" (MFN) rule for bringing down prescription drug prices remains uncertain as President-elect Joe Biden prepares to assume office later this month.

Read Article

RheumNow Podcast – Lights, Camera, Zoom (1.8.2021)

Jan 08, 2021

Dr. Jack Cush reviews the news, journal articles and favorite blogs from this past week on RheumNow.com.

Read Article
EULAR Guidance on Patient Adherence to Meds--Non-adherence may be the single most untold risk to suboptimal outcomes in the care of musculoskeletal disease. https://t.co/XwxkFz66fv https://t.co/E6W3H56jps
Dr. John Cush RheumNow ( View Tweet)
Jan 08, 2021
×